Narrative review / 2012
A review of epidemiologic studies found no consistent or credible evidence linking dietary acrylamide intake to increased cancer risk.
Researchers critically reviewed more than 15 epidemiologic studies (reported in over two dozen papers) examining estimated dietary acrylamide exposure and major cancer sites, evaluating results overall and separately for never smokers or adjusted for smoking. The review found no consistent or credible evidence that dietary acrylamide increases the risk of any type of cancer in humans, including breast, endometrial, or ovarian cancers. The sporadically and slightly altered risk ratios reported across studies were considered strongly suggestive of a true null association.
Shows an association, not proof of cause and effect.
- Study type
- Critical review of epidemiologic studies
- Who was studied
- Human participants across more than 15 epidemiologic studies
- What was measured
- Risk of various cancers, including breast, endometrial, and ovarian cancers
THE PAPER
Review of epidemiologic studies of dietary acrylamide intake and the risk of cancer.
Lipworth L, Sonderman JS, Tarone RE, McLaughlin JK. Eur J Cancer Prev, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.